MAI Capital Management’s Sana Biotechnology SANA Stock Holding History

MAI Capital Management’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$130K	Buy	37,303 +36,611	+5,291%	+$118K	﹤0.01%	1886
2026 Q1	$1.99K	Buy	692 +218	+46%	+$859	﹤0.01%	3928
2025 Q4	$1.93K	Hold	474	–	–	﹤0.01%	3430
2025 Q3	$1.68K	Hold	474	–	–	﹤0.01%	3353
2025 Q2	$1.29K	Buy	+474	New	+$978	﹤0.01%	3553

Other funds holding SANA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

MAI Capital Management's SANA Position: Q2 2026 in Review

MAI Capital Management increased its Sana Biotechnology (SANA) stake by 5,291% in Q2 2026, buying an estimated $118K and bringing the position to 37,303 shares worth $130K. The position accounts for ﹤0.01% of the portfolio, ranked #1886.

MAI Capital Management first reported a position in SANA in Q2 2025 and has held it in 5 quarters since. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

MAI Capital Management held 37,303 shares of Sana Biotechnology worth $130K as of Q2 2026.
MAI Capital Management bought 36,611 Sana Biotechnology shares in Q2 2026, an estimated $118K.
Sana Biotechnology made up ﹤0.01% of MAI Capital Management's portfolio in Q2 2026, its #1886 holding.
MAI Capital Management first reported a position in Sana Biotechnology in Q2 2025 and has held it in 5 quarters since.
211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.